Document is current

Any future updates will be listed below

Correction to: Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS

Crossref DOI link: https://doi.org/10.1007/s40256-021-00517-2

Published Online: 2021-12-21

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark